Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2012	Dec. 31, 2011
Statement of Financial Position [Abstract]
Allowance, accounts receivable	$ 0	$ 0
Accumulated amortization, patent costs	81,619	78,851
Discount, notes payable	$ 17,350	$ 18,589
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	75,000,000	75,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	175,000,000	175,000,000
Common stock, shares issued	174,940,506	174,940,506
Common stock, shares outstanding	145,144,603	145,144,603
Treasury stock, shares	29,795,903	29,795,903